[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100565159":3},{"organization":4,"armGroups":7,"interventions":29,"overallOfficials":48,"centralContacts":53,"locations":62,"responsibleParty":85,"collaborators":88,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":98,"acronym":99,"eligibilityCriteria":100,"healthyVolunteers":96,"sex":101,"minAge":102,"maxAge":103,"enrollmentInfo":104,"targetDuration":35,"studyType":107,"phases":108,"briefSummary":110,"conditions":111,"keywords":35,"overallStatus":65,"whyStopped":35,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":124},{"fullName":5,"class":6},"Abramson Cancer Center at Penn Medicine","OTHER",[8,15,20,25],{"label":9,"type":10,"description":11,"interventionNames":12},"Active Choice (Stage 1) + Low Touch (Stage 2)","EXPERIMENTAL","Participants in this arm will be offered the option via outreach letter to complete an SDM visit via telehealth or in-person (Stage 1) and if individuals do not schedule an SDM visit within 30 days (non-responders), they will receive asynchronous text messages alone (Stage 2)",[13,14],"Behavioral: Active Choice","Behavioral: Low Touch Strategy",{"label":16,"type":10,"description":17,"interventionNames":18},"Active Choice (Stage 1) + High Touch (Stage 2)","Participants in this arm will be offered the option via outreach letter to complete an SDM visit via telehealth or in-person (Stage 1) and if individuals do not schedule an SDM visit within 30 days (non-responders), they will receive asynchronous text messages in combination with synchronous digital care coordination (Stage 2).",[13,19],"Behavioral: High Touch Strategy",{"label":21,"type":10,"description":22,"interventionNames":23},"Telehealth Only (Stage 1) + Low Touch (Stage 2)","Participants in this arm will be offered the option via outreach letter to complete an SDM visit via telehealth only (Stage 1) and if individuals do not schedule an SDM visit within 30 days (non-responders), they will receive asynchronous text messages alone (Stage 2).",[24,14],"Behavioral: Telehealth Only",{"label":26,"type":10,"description":27,"interventionNames":28},"Telehealth Only (Stage 1) + High Touch (Stage 2)","Participants in this arm will be offered the option via outreach letter to complete an SDM visit via telehealth only (Stage 1) and if individuals do not schedule an SDM visit within 30 days (non-responders), they will receive asynchronous text messages in combination with synchronous digital care coordination (Stage 2).",[24,19],[30,36,40,44],{"type":31,"name":32,"description":33,"armGroupLabels":34,"otherNames":35},"BEHAVIORAL","Active Choice","The participant will be send a letter inviting them to complete a SDM visit either in-person or via telehealth.",[16,9],null,{"type":31,"name":37,"description":38,"armGroupLabels":39,"otherNames":35},"Telehealth Only","The participant will be send a letter inviting them to complete a SDM visit via telehealth only.",[26,21],{"type":31,"name":41,"description":42,"armGroupLabels":43,"otherNames":35},"Low Touch Strategy","Patient will be sent asynchronous text messaging reminders encouraging SDM for LCS using framed messaging.",[9,21],{"type":31,"name":45,"description":46,"armGroupLabels":47,"otherNames":35},"High Touch Strategy","Patient will be sent asynchronous text messaging reminders encouraging SDM for LCS using framed messaging in combination with synchronous telephone-based digital care coordination.",[16,26],[49],{"name":50,"affiliation":51,"role":52},"Katharine Rendle, PhD","Abramson Cancer Center","PRINCIPAL_INVESTIGATOR",[54,58],{"name":50,"role":55,"phone":56,"phoneExt":35,"email":57},"CONTACT","215-349-5442","katharine.rendle@pennmedicine.upenn.edu",{"name":59,"role":55,"phone":60,"phoneExt":35,"email":61},"Hannah Toneff, MSW, MA","267-882-3186","Hannah.Toneff@pennmedicine.upenn.edu",[63],{"facility":64,"status":65,"city":66,"state":67,"zip":68,"country":69,"countryCode":70,"cosmosGeoPoint":71,"geoPoint":76,"contacts":77},"University of Pennsylvania","RECRUITING","Philadelphia","Pennsylvania","19104","United States","US",{"type":72,"coordinates":73},"Point",[74,75],-75.16362,39.95238,{"lat":75,"lon":74},[78,81,82,83],{"name":79,"role":55,"phone":80,"phoneExt":35,"email":57},"Katharine Rendle, PhD,MSW,MPH","215-349- 5442",{"name":59,"role":55,"phone":60,"phoneExt":35,"email":61},{"name":79,"role":52,"phone":35,"phoneExt":35,"email":35},{"name":84,"role":52,"phone":35,"phoneExt":35,"email":35},"Anil Vachani, MD",{"type":52,"investigatorFullName":86,"investigatorTitle":87,"investigatorAffiliation":5,"oldNameTitle":35,"oldOrganization":35},"Katharine Rendle","Associate Professor",[89,92],{"name":90,"class":91},"National Institutes of Health (NIH)","NIH",{"name":93,"class":91},"National Cancer Institute (NCI)","100565159","integrating-telehealth-to-advance-lung-cancer-screening-100565159",false,"NCT06638554","Integrating Telehealth to Advance Lung Cancer Screening","ITALCS","Inclusion criteria:\n\nParticipants will be eligible if:\n\n1. are aged 50 to 80\n2. have a history of tobacco use indicated by either: Documented 20 pack-year or greater smoking history in their electronic health record (EHR); OR Self-report via structured survey\n3. currently smoke or formerly smoked cigarettes\n4. have no documented history of lung cancer\n5. have no documented history of lung cancer screening in the 24 months prior to study enrollment\n6. have completed at least one primary care visit at Penn Medicine in the 3 years prior to study enrollment.\n\nExclusion criteria:\n\nParticipants who do not meet inclusion criteria will not be eligible.","ALL","50 Years","80 Years",{"count":105,"type":106},6000,"ESTIMATED","INTERVENTIONAL",[109],"NA","The goal of this pragmatic trial is to learn if telehealth strategies can increase shared decision-making (SDM) for lung cancer screening (LCS). It will also learn about the equity of these strategies by conducting non-inferiority analysis by race and sex. The main questions it aims to answer are:\n\n1. Does patient outreach using synchronous and asynchronous telehealth strategies increase completion of SDM visits for LCS?\n2. Is the effectiveness of these telehealth strategies similar by race and sex?\n\nThe study uses a Sequential Multiple Assignment Randomized Trial (SMART) design and includes two stages of interventions. The first stage of intervention includes direct patient outreach with an invitation to schedule either a 1) telehealth SDM visit or 2) telehealth or in-person SDM visit. Participants that do not respond to the first stage interventions receive a text message reminder encouraging SDM visit completion with or without digital care coordination.",[112,113,114],"Early Detection of Cancer","Telemedicine","Decision Making","2026-05-27",{"date":117,"type":118},"2026-05-29","ACTUAL",{"date":120,"type":118},"2024-07-09",{"date":122,"type":106},"2027-06-30",{"name":5,"class":6},1]